Amiodarone pretreatment of organ donors exerts anti-oxidative protection but induces excretory dysfunction in liver preservation and reperfusion

Liver Transplantation

Volumn 15, Issue 7, 2009, Pages 763-775

  Moussavian, Mohammed Reza ^a   Kollmar, Otto ^a   Schmidt, Michael ^a   Scheuer, Claudia ^a   Wagner, Matthias ^a   Siotta, Jan Erik ^a   Gronow, Gernot ^b   Justinger, Christoph ^a   Menger, Michael Dieter ^a   Schilling, Martin Karl ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CASPASE 3; GLUTAMATE DEHYDROGENASE; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BILE ACID METABOLISM; BILE FLOW; COLD ISCHEMIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER HISTOLOGY; LIVER PRESERVATION; LIVER TRANSPLANTATION; LIVER WEIGHT; MITOCHONDRION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SHAM PROCEDURE; WESTERN BLOTTING;

AMIODARONE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASES; ENZYME INHIBITORS; FEMALE; HEME OXYGENASE-1; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; ORGAN TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 68349160469     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21757     Document Type: Article

References (44)

1. Eurotransplant Annual Report 2007. Available at: http://www.eurotransplant.nl/files/annual_report/AR2007_def. pdf. Accessed January 2009.
2. Wolff M, Kalff JC, Schwarz NT, Lauschke H, Minor T, Tolba RH, Hirner A. Liver transplantation in Germany. Zentralbl Chir 2003;128:831-841.
3. Moussavian MR, Kollmar O, Jacob P, Richter S, Schilling MK. Legislation on organ donation. An internet based survey. Tx Med 2007;19:117-122.
4. Zhang SJ, Ma TW, Ma XX, Gou JJ, Shi JH, Guo WZ. Protective effects of N-acetylcysteine on brain-dead rat liver. Hepatobiliary Pancreat Dis Int 2006;5:428-431.
5. Cicco G, Panzera PC, Catalano G, Memeo V. Microcirculation and reperfusion injury in organ transplantation. Adv Exp Med Biol 2005;566:363-373.
6. Richter S, Yamauchi J, Minor T, Menger MD, Vollmar B. Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non-heart-beating donor rat-model. Transpl Int 2000;13: 225-229.
7. Di Pasquale G, Pinelli G, Andreoli A, Manini G, Grazi P, Tognetti F. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 1987; 59:596-600.
8. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617-623.
9. Cheung RT, Hachinski V. Cardiac effects of stroke. Curr Treat Options Cardiovasc Med 2004;6:199-207.
10. Colivicchi F, Bassi A, Santini M, Caltagirone C. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke 2004;35:2094-2098.
11. Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851-2856.
12. Salim A, Martin M, Brown C, Belzberg H, Rhee P, Demetriades D. Complications of brain death: frequency and impact on organ retrieval. Am Surg 2006;72:377-381.
13. Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a level I trauma center. J Trauma 1990;30:728-732.
14. Tomlinson DR, Cherian P, Betts TR, Bashir Y. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment? Emerg Med J 2008;25:15-18.
15. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007; 298:1312-1322.
16. Lapenna D, Ciofani G, Bruno C, Pierdomenico SD, Cuccurullo F. Antioxidant activity of amiodarone on human lipoprotein oxidation. Br J Pharmacol 2001;133:739-745.
17. Chan AL, Hsieh HJ, Hsieh YA, Lin SJ. Fatal amiodarone-induced hepatotoxicity: a case report and literature review. Int J Clin Pharmacol Ther 2008;46:96-101.
18. Rätz Bravo AE, Drewe J, Schlienger RG, Krähenbühl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med 2005;33: 128-134.
19. Reasor MJ, McCloud CM, Beard TL, Ebert DC, Kacew S, Gardner MF, et al. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats. Toxicology 1996;106: 139-147.
20. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.
21. Feld GK, Nademanee K, Weiss J, Stevenson W, Singh BN. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. J Am Coll Cardiol 1984;3:1298-1307.
22. Toyama J, Kamiya K, Cheng J, Lee JK, Suzuki R, Kodama I. Ion channel blockers in the treatment of chronic heart failure. J Card Fail 1996;2:243-249.
23. Klotz U. Antiarrhythmics: elimination and dosage considerations in hepatic impairment. Clin Pharmacokinet 2007;46:985-996.
24. Waldhauser KM, Török M, Ha HR, Thomet U, Konrad D, Brecht K, et al. Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 2006;319:1413-1423.
25. Nicolescu AC, Ji Y, Comeau JL, Hill BC, Takahashi T, Brien JF, et al. Direct mitochondrial dysfunction precedes reactive oxygen species production in amiodarone-induced toxicity in human peripheral lung epithelial HPL1A cells. Toxicol Appl Pharmacol 2008;227:370-379.
26. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 2007;39:443-455.
27. Baudin B, Bénéteau-Burnat B, Giboudeau J. Cytotoxicity of amiodarone in cultured human endothelial cells. Cardiovasc Drugs Ther 1996;10:557-560.
28. Marzi I, Knee J, Bühren V, Menger M, Trentz O. Reduction by superoxide dismutase of leukocyte-endothelial adherence after liver transplantation. Surgery 1992;111:90-97.
29. Lee WY, Lee SM. Ischemic preconditioning protects postischemic oxidative damage to mitochondria in rat liver. Shock 2005;24:370-375.
30. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation 1999;100:690-692.
31. Ribeiro SM, Campello AP, Nascimento AJ, Kluppel ML. Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism. Cell Biochem Funct 1997;15:145-152.
32. Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, Gallyas F Jr. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther 2003;307:615-625.
33. Xu H, Lee CY, Clemens MG, Zhang JX. Prolonged hypothermic machine perfusion preserves hepatocellular function but potentiates endothelial cell dysfunction in rat livers. Transplantation 2004;77:1676-1682.
34. Jonas E, Näslund E, Freedman J, Befrits R, Blomqvist L, Siösteen AK, et al. Measurement of parenchymal function and bile duct flow in primary sclerosing cholangitis using dynamic 99mTc-HIDA SPECT. J Gastroenterol Hepatol 2006;21:674-681.
35. Smreková R, Vajdová K, Kukan M, Ulicná O, Lutterová M, Wsólová L, Horecký J. A rapid, simple, and cost-effective method for screening liver preservation solutions in the rat. Transplantation 2000;70:430-436.
36. Bowers BA, Branum GD, Rotolo FS, Watters CR, Meyers WC. Bile flow: an index of ischemic injury. J Surg Res 1987;42:565.
37. Hill CE. The anion transport inhibitor DIDS activates a Ba2+-sensitive K+ flux associated with hepatic exocrine secretion. Can J Physiol Pharmacol 1999;77:268-275.
38. Hill CE, Briggs MM, Liu J, Magtanong L. Cloning, expression, and localization of a rat hepatocyte inwardly rectifying potassium channel. Am J Physiol Gastrointest Liver Physiol 2002;282:G233-G240.
39. Ollivier H, Pichavant K, Puill-Stephan E, Roy S, Calvès P, Nonnotte L, Nonnotte G. Volume regulation following hyposmotic shock in isolated turbot (Scophthalmus maximus) hepatocytes. J Comp Physiol 2006;176:393-403.
40. Häussinger D, Reinehr R, Schliess F. The hepatocyte integrin system and cell volume sensing. Acta Physiol (Oxf) 2006;187:249-255.
41. Panayiotidis MI, Bortner CD, Cidlowski JA. On the mechanism of ionic regulation of apoptosis: would the Na+/K+-ATPase please stand up? Acta Physiol (Oxf) 2006;187: 205-215.
42. Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989;9:679-685.
43. Norris W, Paredes AH, Lewis JH. Drug-induced liver injury in 2007. Curr Opin Gastroenterol 2008;24:287-297.
44. Lim PK, Trewby PN, Storey GC, Hole DW. Neuropathy and fatal hepatitis in a patient receiving amiodarone. Br Med J (Clin Res Ed) 1984;288:1638-1639.